Top 25 van geneesmiddelen die het sterkst zijn gedaald in de vergoeding in 2022
- Raming voor de totale Zvw-populatie
| ATC-code | vergoeding 2022 |
vergoeding 2021 |
absolute daling t.o.v. 2021 |
procentuele daling t.o.v. 2021 |
|
|---|---|---|---|---|---|
| 1 | R07AX31 Ivacaftor met tezacaftor (Symkevi ®) | 3.796.900 | 27.192.700 | -23.395.800 | -86.04% |
| 2 | R07AX30 Ivacaftor met lumacaftor (Orkambi ®) | 15.526.100 | 37.638.900 | -22.112.800 | -58.75% |
| 3 | R03BB04 Tiotropium (Spiriva ®) | 33.616.000 | 39.116.300 | -5.500.300 | -14.06% |
| 4 | V03AC03 Deferasirox (Exjade ®) | 3.109.000 | 5.498.000 | -2.389.000 | -43.45% |
| 5 | J05AR18 Emtricitabine tenofovir alafenamide elvitegravir cobicista (Genvoya ®) | 21.655.000 | 23.652.300 | -1.997.300 | -8.44% |
| 6 | J05AR13 Lamivudine met abacavir en dolutegravir (Triumeq ®) | 18.958.000 | 20.926.900 | -1.968.900 | -9.41% |
| 7 | R03AK06 Salmeterol met fluticason (Seretide ®) | 16.973.700 | 18.776.200 | -1.802.500 | -9.60% |
| 8 | J05AR06 Emtricitabine met tenofovir disoproxil en efavirenz | 911.990 | 2.495.600 | -1.583.610 | -63.46% |
| 9 | L03AX13 Glatirameer (Copaxone ®) | 9.330.900 | 10.807.200 | -1.476.300 | -13.66% |
| 10 | J05AP57 Glecaprevir met pibrentasvir (Maviret ®) | 6.150.500 | 7.589.200 | -1.438.700 | -18.96% |
| 11 | L04AA27 Fingolimod (Gilenya ®) | 23.853.100 | 25.289.700 | -1.436.600 | -5.68% |
| 12 | L04AX03 Methotrexaat (Injexate ®) | 19.076.500 | 20.240.900 | -1.164.400 | -5.75% |
| 13 | L03AB07 Interferon beta 1a (Avonex ®) | 7.813.000 | 8.898.500 | -1.085.500 | -12.20% |
| 14 | A10AD05 Insuline aspart (Novomix 30 ®) | 8.807.000 | 9.847.500 | -1.040.500 | -10.57% |
| 15 | R03AK07 Formoterol met budesonide (Symbicort ®) | 24.065.900 | 25.089.600 | -1.023.700 | -4.08% |
| 16 | G04CA52 Tamsulosine met dutasteride (Combodart ®) | 2.258.300 | 3.223.300 | -965.000 | -29.94% |
| 17 | R05CB13 Deoxyribonuclease (Pulmozyme ®) | 3.453.700 | 4.331.800 | -878.100 | -20.27% |
| 18 | J06BD01 Palivizumab (Synagis ®) | 8.360.200 | 9.142.100 | -781.900 | -8.55% |
| 19 | J05AR08 Emtricitabine met tenofovir disoproxil en rilpivirine (Eviplera ®) | 2.191.600 | 2.969.800 | -778.200 | -26.20% |
| 20 | N02AA05 Oxycodon (Oxynorm ®) | 6.482.900 | 7.214.800 | -731.900 | -10.14% |
| 21 | L01BB02 Mercaptopurine (Puri-nethol ®) | 913.210 | 1.635.400 | -722.190 | -44.16% |
| 22 | H01CB03 Lanreotide (Somatuline ®) | 21.726.300 | 22.420.300 | -694.000 | -3.10% |
| 23 | H01CB02 Octreotide (Sandostatine ®) | 14.470.500 | 15.103.300 | -632.800 | -4.19% |
| 24 | L02BA03 Fulvestrant (Faslodex ®) | 7.027.400 | 7.655.000 | -627.600 | -8.20% |
| 25 | J05AR09 Emtricitabine met tenofovir elvitegravir en cobicistat (Stribild ®) | 4.841.900 | 5.405.000 | -563.100 | -10.42% |